Bristol-Myers Squibb, Bayer team up on Opdivo-Stivarga combo in colorectal cancer
admin 18th July 2019 Uncategorised 0Bristol-Myers Squibb is out to expand the pool of colorectal cancer patients it can treat with Opdivo—and it’s bringing in Bayer to help. The duo plan to test the I-O star alongside Bayer’s Stivarga, hoping to gain a new FDA approval that can boost both drugs’ sales.
More: Bristol-Myers Squibb, Bayer team up on Opdivo-Stivarga combo in colorectal cancer
Source: fierce